Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Posey

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|August 8, 2002
Case series: use of ziprasidone for maladaptive symptoms in youths with autismChristopher J McDougle, Deborah L Kem, David J Posey
Journal of Child and Adolescent Psychopharmacology|January 15, 2005
Aripiprazole for maladaptive behavior in pervasive developmental disordersKimberly A Stigler, David J Posey, Christopher J McDougle
Pharmacology, Biochemistry, and Behavior|February 7, 2002
The amygdala and related structures in the pathophysiology of autismThayne L Sweeten, David J Posey, Anantha Shekhar, et al.
Biological Psychiatry|February 13, 2004
High nitric oxide production in autistic disorder: a possible role for interferon-gammaThayne L Sweeten, David J Posey, Sudha Shankar, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 21, 2010
Aripiprazole in autism spectrum disorders and fragile X syndromeCraig A Erickson, Kimberly A Stigler, David J Posey, et al.
The Journal of Clinical Psychiatry|January 13, 2006
Neurochemistry in the pathophysiology of autismChristopher J McDougle, Craig A Erickson, Kimberly A Stigler, et al.
Paediatric Drugs|February 19, 2004
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and managementKimberly A Stigler, Marc N Potenza, David J Posey, et al.
Expert Review of Neurotherapeutics|November 9, 2005
Risperidone in pervasive developmental disordersCraig A Erickson, Kimberly A Stigler, David J Posey, et al.
Journal of Clinical Psychopharmacology|September 2, 2011
Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulationErica B Bernhardt, Kelda H Walsh, David J Posey, et al.
The Journal of Clinical Psychiatry|June 27, 2008
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disordersChristopher J McDougle, Kimberly A Stigler, Craig A Erickson, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American Academy of Child and Adolescent Psychiatry|August 8, 2002
Case series: use of ziprasidone for maladaptive symptoms in youths with autismChristopher J McDougle, Deborah L Kem, David J Posey
Journal of Child and Adolescent Psychopharmacology|January 15, 2005
Aripiprazole for maladaptive behavior in pervasive developmental disordersKimberly A Stigler, David J Posey, Christopher J McDougle
Pharmacology, Biochemistry, and Behavior|February 7, 2002
The amygdala and related structures in the pathophysiology of autismThayne L Sweeten, David J Posey, Anantha Shekhar, et al.
Biological Psychiatry|February 13, 2004
High nitric oxide production in autistic disorder: a possible role for interferon-gammaThayne L Sweeten, David J Posey, Sudha Shankar, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 21, 2010
Aripiprazole in autism spectrum disorders and fragile X syndromeCraig A Erickson, Kimberly A Stigler, David J Posey, et al.
The Journal of Clinical Psychiatry|January 13, 2006
Neurochemistry in the pathophysiology of autismChristopher J McDougle, Craig A Erickson, Kimberly A Stigler, et al.
Paediatric Drugs|February 19, 2004
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and managementKimberly A Stigler, Marc N Potenza, David J Posey, et al.
Expert Review of Neurotherapeutics|November 9, 2005
Risperidone in pervasive developmental disordersCraig A Erickson, Kimberly A Stigler, David J Posey, et al.
Journal of Clinical Psychopharmacology|September 2, 2011
Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulationErica B Bernhardt, Kelda H Walsh, David J Posey, et al.
The Journal of Clinical Psychiatry|June 27, 2008
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disordersChristopher J McDougle, Kimberly A Stigler, Craig A Erickson, et al.
Pageof 7